Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
VALN
VALN
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
VALN News
Valneva SE Announces 2026 Annual General Meeting Details
Jun 04 2026
Newsfilter
Valneva to Present at Multiple Investor Conferences
May 28 2026
Newsfilter
Valneva Adjusts 2026 Financial Outlook Amid Vaccine Uptake Decline
May 13 2026
seekingalpha
Valneva Reports Q1 2026 Financial Results and Updates Guidance
May 13 2026
Newsfilter
Valneva SE to Report Q1 2026 Financial Results on May 13
May 05 2026
Newsfilter
Pomerantz LLP Investigates Valneva for Securities Fraud
May 01 2026
PRnewswire
Valneva Completes €84 Million Reserved Offering Successfully
Apr 30 2026
Newsfilter
Pomerantz LLP Investigates Valneva for Securities Fraud
Apr 28 2026
Globenewswire
Pomerantz LLP Investigates Valneva for Securities Fraud
Apr 21 2026
Globenewswire
Valneva SE Under Investigation for Securities Fraud
Apr 14 2026
Globenewswire
Valneva SE Under Investigation for Securities Fraud
Apr 02 2026
PRnewswire
Pomerantz LLP Investigates Valneva for Securities Fraud
Mar 31 2026
Globenewswire
Biotech Landscape Update: Regulatory Approvals and Mergers
Mar 27 2026
NASDAQ.COM
Valneva to Participate in World Vaccine Congress 2026
Mar 26 2026
Newsfilter
Valneva's Vaccine Trial Fails to Meet Primary Endpoint
Mar 24 2026
Globenewswire
Valneva's Lyme Disease Vaccine Candidate Shows Over 70% Efficacy
Mar 23 2026
NASDAQ.COM
Show More News
